Proteogenomic evaluation of patients with Kidney Cancer treated with immunotherapy
PROTEOGENOMIC EVALUATION OF PATIENTS WITH KIDNEY CANCER TREATED WITH IMMUNOTHERAPY
Role of immune response control molecules/genes (checkpoint) in the pathogeny and ...
Comprehensive characterization of T cells in Pancreatic Ductal Adenocarcinomas
Characterization of the involvement of DUSP12 and its nuclear targets in the respo...
Evaluation of the antitumoral activity of CD39+ T cells in patients with clear cel...
Integrating proteogenomic analysis in immunotherapy-treated kidney cancer patients